E-LIB Suche - Ergebnisse für: Traboulsee, A.

1

Efficacité à long terme du satralizumab dans les troubles d..:

De Sèze, Jérôme ; Palace, Jacqueline ; Traboulsee, Anthony...
Revue Neurologique. 180 (2024) - p. S59 , 2024

Link: https://doi.org/10.1016/..

2

Sécurité et efficacité clinique du Tolebrutinib dans l'étud..:

Oh, Jiwon ; Reich, Daniel S. ; Traboulsee, Anthony...
Revue Neurologique. 180 (2024) - p. S158-S159 , 2024

Link: https://doi.org/10.1016/..

3

Anti-aquaporin-4 immune complex stimulates complement-depen..:

Nishiyama, Shuhei ; Seok, Jin Myong ; Wright, Amy E....
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Health Canada drug approval process: a barrier to personali..:

Oh, Jiwon ; Bhan, Virender ; Traboulsee, Anthony...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. , 2024

Link: https://doi.org/10.1017/..

5

P.014 Intravenous immunoglobulin use for central nervous sy..:

Beadon, K ; Uy, C ; Cross, H...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S18-S18 , 2024

Link: https://doi.org/10.1017/..

6

MRI Outcomes from the Long-term Extension Study of Tolebrut..:

Reich, Daniel ; Traboulsee, Anthony ; Syed, Sana...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

7

Lack of Rebound Disease Activity in Participants with Relap..:

Traboulsee, Anthony ; Fox, Robert ; Arnold, Douglas...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

8

Accounting for uncertainty in training data to improve mach..:

Tayyab, Maryam ; Metz, Luanne M. ; Li, David K.B....
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Direct Health Care Costs Associated With Multiple Sclerosis..:

Khakban, Amir ; Rodriguez Llorian, Elisabet ; Michaux, Kristina D....
Neurology. 100 (2023) 9 - p. , 2023

Link: https://doi.org/10.1212/..

10

MRI, Efficacy, and Safety of Tolebrutinib in Patients with ..:

Fox, Robert ; Oh, Jiwon ; Arnold, Douglas...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

11

Données IRM, efficacité et sécurité d'emploi du tolébrutini..:

Fox, Robert J. ; Oh, Jiwon ; Arnold, Douglas...
Revue Neurologique. 179 (2023) - p. S169-S170 , 2023

Link: https://doi.org/10.1016/..

12

Ocrelizumab exposure in relapsing–remitting multiple sclero..:

Kappos, Ludwig ; Traboulsee, Anthony ; Li, David K. B....
Journal of Neurology. 271 (2023) 2 - p. 642-657 , 2023

Link: https://doi.org/10.1007/..

13

International Consensus on Smoldering Disease in Multiple S..:

Bagnato, Francesca ; Scalfari, Antonio ; Oh, Jiwon...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

14

Ocrelizumab-treated patients with relapsing multiple sclero..:

Kolind, Shannon ; Gaetano, Laura ; Assemlal, Haz-Edine...
Multiple Sclerosis Journal. 29 (2023) 6 - p. 741-747 , 2023

Link: https://doi.org/10.1177/..

15

SAkuraBONSAI: Protocol design of a novel, prospective study..:

Bennett, Jeffrey L. ; Fujihara, Kazuo ; Kim, Ho Jin...
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..